Premium
Autophagy failure in A lzheimer's disease and the role of defective lysosomal acidification
Author(s) -
Wolfe Devin M.,
Lee Juhyun,
Kumar Asok,
Lee Sooyeon,
Orenstein Samantha J.,
Nixon Ralph A.
Publication year - 2013
Publication title -
european journal of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.346
H-Index - 206
eISSN - 1460-9568
pISSN - 0953-816X
DOI - 10.1111/ejn.12169
Subject(s) - autophagy , lysosome , microbiology and biotechnology , presenilin , biology , organelle , programmed cell death , chemistry , alzheimer's disease , biochemistry , disease , apoptosis , medicine , enzyme , pathology
Abstract Autophagy is a lysosomal degradative process which recycles cellular waste and eliminates potentially toxic damaged organelles and protein aggregates. The important cytoprotective functions of autophagy are demonstrated by the diverse pathogenic consequences that may stem from autophagy dysregulation in a growing number of neurodegenerative disorders. In many of the diseases associated with autophagy anomalies, it is the final stage of autophagy–lysosomal degradation that is disrupted. In several disorders, including A lzheimer's disease ( AD ), defective lysosomal acidification contributes to this proteolytic failure. The complex regulation of lysosomal p H makes this process vulnerable to disruption by many factors, and reliable lysosomal p H measurements have become increasingly important in investigations of disease mechanisms. Although various reagents for p H quantification have been developed over several decades, they are not all equally well suited for measuring the p H of lysosomes. Here, we evaluate the most commonly used p H probes for sensitivity and localisation, and identify L yso S ensor yellow/blue‐dextran, among currently used probes, as having the optimal profile of properties for measuring lysosomal p H . In addition, we review evidence that lysosomal acidification is defective in AD and extend our original findings, of elevated lysosomal p H in presenilin 1 ( PS 1)‐deficient blastocysts and neurons, to additional cell models of PS 1 and PS 1/2 deficiency, to fibroblasts from AD patients with PS 1 mutations, and to neurons in the PS / APP mouse model of AD .